Stay updated on SAGE-217 in Severe Postpartum Depression Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 in Severe Postpartum Depression Clinical Trial page.

Latest updates to the SAGE-217 in Severe Postpartum Depression Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedExpanded the study location list to include Arkansas, California, District of Columbia, Florida, Georgia, Illinois, Kentucky, Louisiana, Missouri, Nevada, New York, North Carolina, Rhode Island, Texas, and Utah. Removed the HHS Vulnerability Disclosure link from the page.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe Publications section now states that publications are voluntarily entered and may be auto-filled from PubMed, and the Revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page no longer displays the government funding/lapse notice about information updates.SummaryDifference0.3%

- Check62 days agoChange DetectedNo significant changes detected between the two screenshots; any observed differences appear to be minor UI/layout adjustments only. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check91 days agoChange DetectedPage updates to version v3.1.0 with removal of Drug Safety, Counterfeit Drugs, and Substandard Drugs; no new substantive content is shown besides the version upgrade.SummaryDifference0.2%

Stay in the know with updates to SAGE-217 in Severe Postpartum Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 in Severe Postpartum Depression Clinical Trial page.